FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.
FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
EPA finalizes hazardous air pollutant emission standards for plywood and composite wood products facilities, setting maximum achievable control technology limits for formaldehyde, acetaldehyde, and other HAP compounds at major source facilities.
EPA received pesticide product registration applications for new uses of currently registered active ingredients and solicits public comments on the April 2026 compilations.
EPA accepts public comments on new pesticide product registration applications containing previously unregistered active ingredients, with details on 2025 submissions under Federal Insecticide, Fungicide, and Rodenticide Act procedures.
CDC seeks public comment on a proposed Management Information System for Comprehensive Cancer Control Programs that will conduct annual key informant interviews and biennial surveys to monitor program outcomes.
CDC seeks public comment through [date] on the Expanding PrEP in Communities of Color (EPICC) data collection effort, which supports shared decision-making training and evaluation for preexposure prophylaxis providers serving diverse populations.
CDC seeks public comment on a data collection for mChoice, a research study testing tailored provider training and adherence support to improve PrEP uptake among young men who have sex with men in high-priority settings.
DEA issues temporary scheduling order placing 7-hydroxymitragynine above a specified threshold in Schedule I, subjecting manufacturers, distributors, importers, exporters, and researchers to Schedule I controlled substance regulations and penalties.
FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
